Cells change type to help or hinder immunity
Scientists have discovered a mechanism that provides a possible new target for allergy treatments, which may bring hope for asthma sufferers.
List view / Grid view
Scientists have discovered a mechanism that provides a possible new target for allergy treatments, which may bring hope for asthma sufferers.
SMi’s 13th annual Asthma & COPD conference returns to London on the 29 and 30 March 2017...
1 September 2016 | By Niamh Louise Marriott, Digital Content Producer
A collaboration to investigate the link between epigenetics and respiratory disease and to find new drug treatments involves...
15 June 2016 | By Victoria White, Digital Content Producer
MRCT and AstraZeneca are seeking academics with relevant epigenetics targets to collaborate with them to develop novel treatments for respiratory diseases...
18 April 2016 | By Victoria White, Digital Content Producer
A biodegradable nanoparticle, developed by researchers at Northwestern Medicine, offers an innovative way to halt asthma...
8 March 2016 | By Victoria White
Researchers have identified that nociceptin has substantial activity in asthma models given before or during an asthma attack...
15 July 2015 | By Victoria White
Weizmann Institute scientists have shown how it might be possible to use embryonic stem cells to repair damaged lung tissue...
2 March 2015 | By MRC Technology
Project focused on potential small molecule or antibody targets in pathways important in the development or progression of respiratory disease...
11 September 2014 | By Ario Pharma
New chemistry strengthens Ario Pharma’s existing TRPA1 asthma programme and reduces time to selection of new drug candidates...
12 June 2014 | By AstraZeneca
AstraZeneca announced a global licence agreement with Synairgen Plc for SNG001, a novel, inhaled interferon beta (IFN-beta) in clinical development for treating respiratory tract viral infections in patients with severe asthma...